RE:RE:The FUTURE? just need to look at today! Does a breakdown really matter with total sales of $17,000? With regards to why they bought Juvente, see the comments from the 2018 MD&A. Why CZO thinks they can purchase a tiny cosmeceuticals company and are better at marketing than established billion dollar companies is something I'd like to know.
Not sure what their exact goal is at the NYSCC, however based on past results I wouldn't expect much to come from it (no matter what the intent is).
Juvente was acquired to execute on a strategic market diversification strategy to expand the Company’s product portfolio with the development of formulations that utilize the Company’s two value drivers, beta glucan, and avenanthramides, and to enable the Company to enter into the high-end cosmeceuticals market and market directly to the end-user. The development of the formulations and new market would assist the Company with the strategy of utilizing the formulations as a delivery system for various bio-actives.
Minty_33 wrote: “All this new technology, new chemical compounds, while "interesting" have resulted in NO NEW SALES, if no-one buys, it is worthless--------MUCH LIKE THE WHOLE JUVENTE VENTURE!”
I would love to see the breakdown of Juvente sales
online versus retail in brick and mortar. Underwhelming is most certain in both cases I’m sure.
But the acquisition of Juvente must have been for another reason other than to generate minuscule sales in the very competitive cosmetics space. IMO, they will do deals with a major player in the cosmetics arena and perhaps contract manufacturing with small to medium sized companies. There is no point in doing the grind alone to bring in revenue in this space. You can only buy Juvente in a few select stores in Quebec and nowhere else for the time being except online. What is the main goal of exhibiting at the NYSCC ? Can ANYBODY shed some light into this?